IP Library › Assignment 042435/0916
Patent Assignment
Reel/Frame 042435/0916

Dissolution and Transfer of Rights

Recorded: 2017-05-10 Pages: 19
Assignor
DNA THERAPEUTICS
Executed: 2016-09-28
Assignee
ONXEO
49 BOULEVARD DU GÉNÉRAL MARTIAL VALIN, PARIS, 75015, FRANCE
Covered Properties (3)
Optimized In Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates
Patent: 9,205,099 →
Application: 13/703,965 →
Publication: US 2013/0131155
Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates
Patent: 9,428,538 →
Application: 14/923,482 →
Publication: US 2016/0046662
Optimized in Vivo Delivery System with Endosomolytic Agents for Nucleic Acid Conjugates
Patent: 9,687,557 →
Application: 15/232,844 →
Publication: US 2016/0339107
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 5, 2013
From: SUN, JIAN-SHENG; DUTREIX, MARIE; QUANZ, MARIA
To: DNA THERAPEUTICS; INSTITUT CURIE; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 029757/0147 →
Assignment of Assignor's Interest Oct 27, 2015
From: SUN, JIAN-SHENG; DUTREIX, MARIE; QUANZ, MARIA
To: DNA THERAPEUTICS; INSTITUT CURIE; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 036892/0487 →
Assignment of Assignor's Interest Aug 10, 2016
From: SUN, JIAN-SHENG; DUTREIX, MARIE; QUANZ, MARIA
To: DNA THERAPEUTICS; INSTITUT CURIE; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Reel/Frame 039392/0496 →
Change of Name Nov 7, 2023
From: ONXEO
To: VALERIO THERAPEUTICS
Reel/Frame 065489/0815 →